We have seen patients with various arrhythmias, not necessarily AF, during the surge in COVID patients. We observed that most patients admitted to our Cardiology Tertiary Hospital (270+ bedded facility) had patients of all presentations but most of whom came out positive for covid were those suffering from arrhythmias, blocks, tachy, af, vt etc..

Yes but i am particularly talking about AF in COVID-19 with Pneumonia patient. Have any intervention needed for such cases? We found a case developed acute ishcemic stroke following the event despite anticoagulation with enoxaparin.

Emphasis is on ruling out any coexisting possibly underlying condition (ASD with paradox embolism, Imflammation leading to plaque rupture in Carotid Artery, etc.)

At the moment there only exists consensus on VTE prevention by low molecular heparin. Which does not cover all possible events.

Given your experience and in case of ischemic stroke likely to be resulting from thrombembolism from the left atrial appendage due to persisting AFIB you should consider prescribing NOACs in the patients eligible due to CHADsVASc of one or higher, irrespective of COVID. I would also consider prescription right away since you do not know the onset of Afib in most cases. If sinus rhythm resumes after COVID and is well documented over a longer period of time, you can always stop the oral anticoagulation again.

If all other possible reasons for ischemic stroke are ruled out and you are confident to state that your patient had an ischemic stroke due to acute onset of AFIB due to COVID you should consider publishing this case report.

Outstanding observation..Than you...

I recommend you to read:

"COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications" by

Monika Gawałko

, Agnieszka Kapłon-Cies´licka

, Mathias Hohl

, Dobromir Dobrev

,Dominik Linz

They speak specifically on AFib related to Covid-19 patients (19%-21%). Also refer to pneumonia.